Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Comparative analysis of small molecule drugs for nonsense suppression therapy in Choroideremia

Mariya Moosajee; Dhani Tracey-White; Matthew Smart; Carmen Bertoni; Timor Baasov; Andrew Webster

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1105.

ARVO Annual Meeting Abstract September 2016

Small molecules for targeting nonsense mutations causing ciliopathies

Fabian Möller; Ananya Samanta; Inessa Penner; Timor Baasov; Uwe Wolfrum; Kerstin Nagel-Wolfrum

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1184.

ARVO Annual Meeting Abstract March 2012

A Comparative Evaluation Of Translational Read-through Inducing Drugs For Treatment Of Ush

Kerstin Nagel-Wolfrum; Tobias Goldmann; Fabian Möller; Nora Overlack; Valery Belakhov; Timor Baasov; Uwe Wolfrum

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5576.

Physiology and Pharmacology December 2010

Beneficial Read-Through of a USH1C Nonsense Mutation by Designed Aminoglycoside NB30 in the Retina

PDF

Tobias Goldmann; Annie Rebibo-Sabbah; Nora Overlack; Igor Nudelman; Valery Belakhov; Timor Baasov; Tamar Ben-Yosef; Uwe Wolfrum; Kerstin Nagel-Wolfrum
TAGS: aminoglycosides, mutation, nonsense, reading (activity), retina
Invest. Ophthalmol. Vis. Sci.. 2010; 51(12):6671-6680. https://doi.org/10.1167/iovs.10-5741

Advertisement